We can't find the internet
Attempting to reconnect
Something went wrong
Hang in there while we get back on track
£495.00
It has never been this cheap. We have no record of a lower price.
£495 today · cheaper than every other day in the last 3 months
2023-2028 Hypercalcemia Treatment Outlook for China
We'll watch every seller, every day. One email when your price arrives.
Price History & Forecast
Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.
Last 38 days · 38 data points (no recent data)
NEW HERE?
Amazon shows you one price. We show you all of them.
Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.
WHAT'S ON THIS PAGE
when this has been cheap or pricey
where the price is heading next
all-time high & low, recent range
name your number, we'll email you
Price Distribution
Price distribution over 38 days • 1 price levels
Price Analysis
Most common price: £495 (38 days, 100.0%)
Price range: £495 - £495
Price levels: 1 different prices over 38 days
Description
Key Features
Covers latent demand forecasts for hypercalcemia treatments across all Chinese regions including provinces, autonomous regions, municipalities, and special administrative regions plus Taiwan.
Provides potential industry earnings (P.I.E.) estimates for approximately 1,100 cities throughout China to identify high-opportunity markets.
Includes regional analysis showing each major city's percentage share of provincial and national demand.
Spans the 2023-2028 outlook period, enabling five-year strategic planning for pharmaceutical and healthcare organisations.
Published by ICON Group International, Inc., a recognised source for market research and demand forecasting reports.
Product Specifications
- Format
- paperback
- ASIN
- B0BBJHK6JZ
- Category
- Books > Subjects
- Domain
- Amazon UK
- Release Date
- 16 August 2022
- Listed Since
- 26 August 2022
Similar Products You Might Like
The 2023-2028 Outlook for Hypercalcemia Treatments in India
The 2023-2028 Outlook for Osteoporosis Treatments in India
The 2016-2021 Outlook for Calcium Supplements in Greater China
The 2023-2028 Outlook for Pet Veterinary Drugs in China
The 2027-2032 World Outlook for Calcium D-Glucarate
The 2023-2028 Outlook for Calcium and Vitamin D Supplements in India
The 2023-2028 Outlook for Hepatitis Therapeutics in the United States
The 2023-2028 Outlook for Vitamin Deficiency Treatments for US Zip Codes
The 2019-2024 Outlook for Sun Care Products in China
The 2023-2028 Outlook for Diabetic Nephropathy Treatments in India
The 2023-2028 Outlook for Pharmaceuticals for US Zip Codes
The 2023-2028 Outlook for Pruritus Corticosteroid Therapeutics in India
The 2016-2021 Outlook for Pharmaceutical Preparations for Human Use Affecting Neoplasms, the Endocrine System, and Metabolic Diseases in Greater China
The 2023-2028 Outlook for Rheumatology Therapeutics in India
The 2023-2028 Outlook for Cystic Fibrosis Therapeutics for US Zip Codes
The 2023-2028 Outlook for Atrophic Scars Treatments for US Zip Codes
The 2023-2028 Outlook for Hyperhidrosis Treatments for US Zip Codes
The 2023-2028 Outlook for Chronic Disease Management Therapeutics and Device Technologies in the United States
The 2023-2028 Outlook for Cushing's Syndrome Diagnostics and Treatments in the United States
The 2023-2028 Outlook for Anti-Viral Nucleotide Polymerase Inhibitor Drugs in the United States
The 2023-2028 Outlook for Thyroid Gland Disorders in India
The 2023-2028 Outlook for Antifungal Drugs in India
The 2023-2028 Outlook for Amino Acid Metabolism Disorders Treatments in the United States